Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Stroke in cancer patients.

Literature DB >> 16635426

Stroke in cancer patients.

Abstract

Cancer patients are at increased risk for stroke from direct and indirect effects of their malignancy. Some tumors are at high risk for cerebrovascular complications. Certain stroke mechanisms are specific to cancer, such as compression and occlusion of cerebral vessels by tumor, coagulopathy predisposing to hemorrhage and thrombosis, and treatment-related atherosclerosis. Special consideration for these mechanisms needs to be made when evaluating cancer patients, and treatment aimed at secondary prevention needs to incorporate overall prognosis and goals of care.

Entities: Disease Species

Mesh：

Substances：
Antineoplastic Agents

Year: 2006 PMID： 16635426 DOI： 10.1007/s11910-006-0004-0

Source DB: PubMed Journal: Curr Neurol Neurosci Rep ISSN： 1528-4042 Impact factor: 5.081

32 in total

1. Cerebral sinus thrombosis with tamoxifen.

Authors: P F Finelli; P K Schauer
Journal: Neurology Date: 2001-04-24 Impact factor: 9.910

2. Tamoxifen: a new risk factor for cerebral sinus thrombosis.

Authors: J Masjuan; J Pardo; J M Callejo; M T Andrés; J C Alvarez-Cermeño
Journal: Neurology Date: 2004-01-27 Impact factor: 9.910

3. The pattern of cancer in a large cohort of stroke patients.

Authors: K Lindvig; H Møller; J Mosbech; O M Jensen
Journal: Int J Epidemiol Date: 1990-09 Impact factor: 7.196

4. Nonbacterial thrombotic endocarditis (NBTE) and disseminated intravascular coagulation (DIC): autopsy study of 36 patients.

Authors: H S Kim; M Suzuki; J T Lie; J L Titus
Journal: Arch Pathol Lab Med Date: 1977-02 Impact factor: 5.534

5. [Non-bacterial thrombosing endocarditis].

Authors: R Loire; A Tabib; J C Normand
Journal: Arch Mal Coeur Vaiss Date: 1981-02

Review 6. The cerebrovascular risks associated with tamoxifen use.

Authors: Cheryl Bushnell
Journal: Expert Opin Drug Saf Date: 2005-05 Impact factor: 4.250

7. A case with cerebral thrombosis receiving tamoxifen treatment.

Authors: G Akdal; B Dönmez; H Cakmakçi; G G Yener
Journal: Eur J Neurol Date: 2001-11 Impact factor: 6.089

8. Non-bacterial thrombotic endocarditis associated with malignant disease: a clinicopathological study of 16 cases.

Authors: V J Ojeda; F Frost; F L Mastaglia
Journal: Med J Aust Date: 1985-06-10 Impact factor: 7.738

9. Cerebral embolism in cancer patients.

Authors: J H Kearsley; M H Tattersall
Journal: Q J Med Date: 1982

10. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.

Authors: Lesley G Mitchell; Maureen Andrew; Kim Hanna; Thomas Abshire; Jacqueline Halton; Ron Anderson; Irene Cherrick; Sunil Desai; Donald Mahoney; Patricia McCuster; John Wu; Gary Dahl; Peter Chait; Gabrielle de Veber; Kyong-Jin Lee; David Mikulis; Jeffrey Ginsberg; Cliford Way
Journal: Cancer Date: 2003-01-15 Impact factor: 6.860

14 in total

1. Clinical manifestation of cancer related stroke: retrospective case-control study.

Authors: Jeong-Min Kim; Keun-Hwa Jung; Kee Hong Park; Soon-Tae Lee; Kon Chu; Jae-Kyu Roh
Journal: J Neurooncol Date: 2013-01-09 Impact factor: 4.130

2. Platelet count is associated with outcome in cancer patients with stroke.

Authors: Bernardo Cacho-Díaz; Héctor Spínola-Maroño; Laura G Mendoza-Olivas; Myrna Candelaria
Journal: J Neurooncol Date: 2018-08-18 Impact factor: 4.130

3. Nonbacterial Thrombotic Endocarditis Due to Primary Gallbladder Malignancy with Recurrent Stroke Despite Anticoagulation: Case Report and Literature Review.

Authors: Marissa K Shoji; June-Ho Kim; Salina Bakshi; Nicolas Govea; Nareh Marukian; Sally J Wang
Journal: J Gen Intern Med Date: 2019-07-16 Impact factor: 5.128

Stroke in cancer patients.

1. Cerebral sinus thrombosis with tamoxifen.

2. Tamoxifen: a new risk factor for cerebral sinus thrombosis.

3. The pattern of cancer in a large cohort of stroke patients.

4. Nonbacterial thrombotic endocarditis (NBTE) and disseminated intravascular coagulation (DIC): autopsy study of 36 patients.

5. [Non-bacterial thrombosing endocarditis].

Review 6. The cerebrovascular risks associated with tamoxifen use.

7. A case with cerebral thrombosis receiving tamoxifen treatment.

8. Non-bacterial thrombotic endocarditis associated with malignant disease: a clinicopathological study of 16 cases.

9. Cerebral embolism in cancer patients.

1. Clinical manifestation of cancer related stroke: retrospective case-control study.

2. Platelet count is associated with outcome in cancer patients with stroke.

3. Nonbacterial Thrombotic Endocarditis Due to Primary Gallbladder Malignancy with Recurrent Stroke Despite Anticoagulation: Case Report and Literature Review.

4. Stroke in cancer patients: a risk factor analysis.

Review 5. Common Vascular Toxicities of Cancer Therapies.

6. Increase in stroke risk in patients with head and neck cancer: a retrospective cohort study.

7. Atrial fibrillation in cancer patients who develop stroke.

8. Stroke among cancer patients.

9. Cancer-Associated Stroke: The Bergen NORSTROKE Study.

10. A Population-Based Study of 30-day Incidence of Ischemic Stroke Following Surgical Neck Dissection.